Skip to content

Study on early risk stratification and treatment process of patients with acute chest pain

Study on early risk stratification and treatment process of patients with acute chest pain

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088432
Enrollment
Unknown
Registered
2024-08-19
Start date
2021-05-17
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Trial group:Diagnosis and treatment were performed based on improved HEART score
Control group:Conduct diagnosis and treatment based on clinical routine diagnosis and treatment procedures

Sponsors

Fuwai Hospital CAMS&PUMC
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1: over 18 years old, male or female; 2. Patients presenting with acute chest pain with unspecified suspected ACS or suspected myocardial ischemia-related symptoms (such as suffocation, chest tightness, seizures of upper limb or jaw discomfort) within 24 hours; 3: At least one ECG and high-sensitivity troponin test were performed, and no ST segment elevation, new abnormal Q wave, or new complete left bundle branch block were found, which are suggestive of acute ST segment elevation myocardial infarction. Patients with known coronary heart disease (including stable coronary heart disease, past myocardial infarction, past coronary revascularization, or known coronary stenosis) could be enrolled. 4. Sign the study informed consent;

Exclusion criteria

Exclusion criteria: 1: Patients with new ST segment elevation =1mm, new abnormal Q wave or new complete left bundle branch block indicating acute ST segment elevation myocardial infarction; 2: High-risk non-ST elevation acute coronary syndrome was diagnosed at admission (GRACE score > 140 points) 3: Persistent chest pain with hypotension or hemodynamic instability; 4: Clear diagnosis of pulmonary embolism, aortic dissection, tension pneumothorax and other high-risk chest pain; 5: Traumatic chest pain; 6: Surgical treatment is planned; 7: There is a mental illness; 8: Incapacitated; 9: Life expectancy is less than 30 days; 10: has been enrolled in other clinical studies; 11: Other situations in which the researcher deems it inappropriate to participate; 12. Refuse to sign the informed consent for the study;

Design outcomes

Primary

MeasureTime frame
Emergency room detention time and heart-assisted examination rate;

Secondary

MeasureTime frame
Predictive value of modified HEART scores for 30-day MACE events;

Countries

China

Contacts

Public ContactYanmin Yang

Fuwai Hospital CAMS&PUMC

yymfuwai@163.com+86 135 0124 1275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026